Lower Acetaminophen Doses Recommended Despite Cost Impact, Lack Of Data
This article was originally published in The Tan Sheet
Executive Summary
A joint advisory committee recommended as a "top priority" that FDA lower the maximum single and daily dose of acetaminophen, despite inconclusive data that the current dose poses significant hepatotoxicity risks